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Abstract The Ile148Met (rs738409, G-allele) in the
patatin-like phospholipase domain-containing protein 3
gene (PNPLA3) associates with liver fat content and may
lead to loss-of-function (hydrolysis) or gain-of-function
(CoA-dependent lysophosphatidic acid acyltransferase)
defects. PNPLA3 is up-regulated by dietary carbohydrates,
and interactions between rs738409 and carbohydrates, and
sugar and x6:x3-polyunsaturated fatty acid (PUFA) ratio
on hepatic fat accumulation have been reported. We
examined interaction between rs738409 and overweight,
and between rs738409 and dietary intakes (carbohydrates,
sucrose and x6:x3-PUFA ratio), on fasting triglyceride
levels. From the Malmo Diet and Cancer Study-Cardio-
vascular Cohort, 4,827 individuals without diabetes aged
58 ± 6 years, 2,346 with BMI B 25 kg/m2 and 2,478 with
BMI [ 25 kg/m2, were included in cross-sectional analy-
ses. Dietary data were collected by a modified diet history
method. Overweight modified the association between
rs738409 and fasting triglyceride levels (Pinteraction =
0.003). G-allele associated with lower triglycerides only
among overweight individuals (P = 0.01). Nominally,
significant interaction on triglyceride levels was observed
between rs738409 and sucrose among normal-weight
individuals (Pinteraction = 0.03). G-allele associated with
lower triglycerides among overweight individuals in the
lowest tertiles of carbohydrate and x6:x3-PUFA ratio
(P = 0.04 and P = 0.001) and with higher triglycerides
among normal-weight individuals in the highest tertile of
sucrose (P = 0.001). We conclude that overweight and
dietary sucrose may modify the association between
rs738409 and fasting triglyceride levels.
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Introduction
A common missense variation Ile148Met (rs738409,
G-allele), in the patatin-like phospholipase domain-con-
taining protein 3 gene (PNPLA3), also named adiponutrin,
was identified associated with liver fat content and non-
alcoholic fatty liver disease (NAFLD) in a genome-wide
association study (GWAS) in 2008 (Romeo et al. 2008).
This association between the 148M (G-allele) and fatty
liver and histological disease severity has since then been
widely replicated in both adults and children (Kotronen
et al. 2009; Kantartzis et al. 2009; Goran et al. 2010;
Hyysalo et al. 2011; Santoro et al. 2010; Valenti et al.
2010; Del Giudice et al. 2011; Romeo et al. 2010a, b). Two
recent studies observed that the PNPLA3 rs738409 GG-
genotype associated with lower serum triglyceride and
cholesterol levels among obese (Palmer et al. 2012) or
glucose-intolerant individuals (Krarup et al. 2012) and was
suggested to be a result of an obesity-driven reduced tri-
glyceride hydrolysis and intrahepatic fat accumulation
(Pirazzi et al. 2012). Indeed, PNPLA3 has been shown to
have a hydrolytic activity against the three major glycer-
olipids (Huang et al. 2011; Pignitore et al. 2013), and the
PNPLA3 148M was also reported to be a loss-of-function
(hydrolysis) variant with a markedly decreased Vmax for
glycerolipids (Huang et al. 2011). Loss of the hydrolysis
function of PNPLA3 by the 148M variant has been indi-
cated in several studies: analysis of VLDL kinetics after a
bolus infusion of stable isotopes in overweight/obese men
revealed that the relative secretion of VLDL1 particles was
lower, the rate of hydrolysis of [3H]—triglycerides during
lipid depletion was decreased, and the cellular accumula-
tion of labeled triglycerides was enhanced in the presence
of excess free fatty acids (FFAs) by the 148M variant
(Pirazzi et al. 2012; He et al. 2010; Perttila et al. 2012).
In addition to lipase activity, both human and mice
PNPLA3 were recently demonstrated to exhibit an acyl-
CoA-dependent lysophosphatidic acid acyltransferase
(LPAAT) activity, which promotes cellular lipid synthesis
by converting LPA to phosphatidic acid (Kumari et al. 2012).
High sucrose diet up-regulates liver PNPLA3 of wild-type
mice, which concomitantly exhibited increased LPAAT
activity. In line with this, human PNPLA3-148M had
increased LPAAT activity, and gain of this function was
proposed to provide a plausible biochemical mechanism for
increased hepatic fat accumulation (Kumari et al. 2012).
PNPLA3 is highly responsive to changes in energy
balance. It is down-regulated by fasting and dramatically
up-regulated by re-feeding (Baulande et al. 2001; Liu et al.
2004; Johansson et al. 2006; Hoekstra et al. 2010). Car-
bohydrate (CHO) feeding up-regulates PNPLA3 in murine
adipose tissue, and liver and glucose stimulate PNPLA3
expression in human hepatocytes via carbohydrate
response element-binding protein (ChREBP) (Perttila et al.
2012; Dubuquoy et al. 2011).
Dietary CHOs and especially sucrose intake has been
proposed as a key player in liver fat deposition due to the
high lipogenic potential of fructose, which stimulates
hepatic de novo lipogenesis (Polson and Thompson 2003;
Le et al. 2009; Maersk et al. 2012; Abdemalek et al. 2010;
Sevastinova et al. 2012). In a study of 154 overweight
Hispanic children, the hepatic fat content correlated posi-
tively with reported CHO and sugar intakes among chil-
dren homozygous for the risk allele (GG-genotype), but not
among C-allele carriers (Davis et al. 2010).
In addition to CHOs, PNPLA3 is up-regulated by certain
fatty acids that inhibit its degradation (Huang et al. 2010).
Moreover, dietary fat and in particular diets rich in x-6 and
low in x-3 polyunsaturated fatty acids (PUFAs) have been
suggested to contribute to metabolic defects in NAFLD
(Cortez-Pinto et al. 2006). In line with this, a study in 127
children and adolescents observed a positive correlation
between the ratio of x-6 and x-3 PUFA intakes and liver
fat content among GG-genotype carriers (Santoro et al.
2012). Finally, the presence of the 148M allele in children
treated with docosahexaenoic acid (22:6 x-3) worsened the
beneficial reduction induced by this fatty acid on hepatic
steatosis (Nobili et al. 2013), and in obese adolescents, the
oxidized fatty acids derived from linoleic acid associated
with markers of liver injury only in PNPLA3 risk-genotype
carriers (Santoro et al. 2014).
In this study, we examine interaction between PNPLA3
rs738409 and overweight on fasting blood triglyceride and
serum alanine aminotransferase (ALT) levels and challenge
the question if rs738409 interacts with dietary intakes of
CHO, sucrose or x-6:x-3 PUFA ratio, on fasting triglyceride
levels in adult Swedes participating the Malmo¨ Diet and
Cancer Study-Cardiovascular Cohort (MDCS-CC).
Subjects and methods
Study population and data collection
The Malmo¨ Diet and Cancer Study (MDCS) is a Swedish
population-based prospective cohort. During 1991–1996,
all women born between 1923–1950 and men born between
1923–1945, living in the city of Malmo¨, were invited to
participate (Berglund et al. 1993; Manjer et al. 2001).
Limited Swedish language skills and mental incapacity
were the only exclusion criteria. The participants filled out
the questionnaires covering socioeconomic, lifestyle and
dietary factors, recorded meals, and underwent a diet his-
tory interview. A total of 28,098 (40 % of the eligible
persons) completed all baseline examinations (Manjer et al.
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2001). From this cohort, 6,103 individuals with a baseline
examination between 1991 and 1994 were randomly
selected to participate in a cardiovascular cohort (MDC-
CC), of whom 5,543 underwent blood sampling under
standardized fasting conditions.
After an overnight fast, blood samples were drawn for
the determination of serum lipids, serum insulin and whole
blood glucose. Blood glucose was determined by a routine
hexokinase method. Triglycerides and total cholesterol
were determined on a DAX 48 automatic analyzer with use
of reagents and calibrators from the supplier of the
instrument (Bayer AB, Goteborg, Sweden). High-density
lipoprotein (HDL) cholesterol was determined by the same
procedure as used for total cholesterol but after precipita-
tion of low-density lipoprotein (LDL) and very low-density
lipoprotein (VLDL) with dextran–sulfate. LDL cholesterol
was calculated from the values for triglycerides, total
cholesterol and HDL cholesterol according to the Friede-
wald formula: LDL = total cholesterol – HDL - (tri-
glycerides/2.2). Homeostasis model assessment for insulin
resistance (HOMA-IR) was used as a measure of insulin
resistance and was calculated with the following formula:
insulin 9 blood glucose/22.5 (Nilsson et al. 2007).
From MDC-CC population (5,543), we excluded 213
individuals with prevalent type 2 diabetes, based on self-
reported diabetes diagnosis or self-reported anti-diabetic
regimen. After exclusion, we were left with 5,330 indi-
viduals, of whom we had information on diet, PNPLA3
rs738409 genotype, BMI and fasting triglycerides for 4,827
individuals.
Of all MDCS participants, a subgroup of 7,198 indi-
viduals participated in another study, the Malmo¨ Pre-
ventive Project (MPP) (Berglund et al. 1996), in which the
ALT measurements were performed using standard clinical
assay. MPP is a prospective cohort of southern Sweden that
was set up during 1974–1992 within the Department of
Medicine at Malmo¨ University Hospital, Sweden. ALT
levels were used to analyze association with rs738409, but
not for interaction with diet as the ALT measurements were
from an earlier time as compared to the MDCS diet
collection.
The ethical committee at Lund University approved
MDCS and MPP, and all the participants have given their
written informed consent.
Dietary data
Dietary intakes were collected at baseline using a combi-
nation of a 7-day menu book for recording of meals that
vary from day to day (lunch and dinner meals), cold bev-
erages and nutrient supplements, and a 168-item diet
questionnaire (covering food regularly consumed during
the past years) for assessment of consumption frequencies
and portion sizes of regularly eaten foods that were not
covered by the menu book. Finally, a 45-min interview
completed the dietary assessment. The mean daily intake of
foods was calculated based on frequency and portion sizes
estimates from the questionnaire and menu book. The food
intake was converted to energy and nutrient intakes using
the MDC nutrient database where the majority of the
nutrient information comes from PC-KOST2-93 from the
National Food Administration in Uppsala, Sweden. The
MDC method is described in detail elsewhere (Callmer
et al. 1993; Wirfalt et al. 2001).
The routines for coding dietary data were slightly altered
in September 1994 to shorten the interview time. This
change did not reveal any major influence on the ranking of
individuals (Callmer et al. 1993). The relative validity of
the MDC method was evaluated in the Malmo Food study
1984–1985 (Wirfalt et al. 2001). The Pearson correlation
coefficients between the reference method and the MDC
method, adjusted for total energy, were in men and women
0.66/0.70 for CHO, 0.60/0.74 for the variable sugar, 0.23/
0.68 for linoleic acid (x-6), 0.55/0.44 for arachidonic acid
(x-6), 0.22/0.58 for a-linolenic acid (x-3), 0.24/0.38 for
eicosapentaenoic acid (x-3), 0.37/0.40 for docosapentae-
noic acid (x-3), and 0.20/0.27 for docosahexaenoic acid
(x-3) (Riboli et al. 1997).
We used the following variables in this study: total
energy (kcal) (including energy from fat, CHOs, protein,
alcohol and fiber), CHO (E%), sucrose (E%), fat (E%),
SFA (E%), MUFA (E%), PUFA (E%), P:S ratio, x-3
PUFA, x-6 PUFA, x-6:x-3 PUFA ratio, and fiber (g/
1,000 kcal). The nutrient densities were calculated by
dividing total nutrient intakes by non-alcohol energy
intake. Tertiles were used as exposure categories of ma-
cronutrients. Individuals with potentially inaccurate reports
of energy (N = 932) were identified as having a ratio of
energy intake to the basal metabolic rate outside the 95 %
CI limits of the physical activity level calculated for each
individual as total energy expenditure. This procedure is
described in detail elsewhere (Mattisson et al. 2005).
Other variables used as potential confounders
Information on age was obtained from the personal iden-
tification number. Body mass index (BMI; kg/m2) was
calculated from direct measurement of weight and height.
Leisure time physical activity was assessed by asking the
participants to estimate the number of minutes per week
they spent on 17 different activities. The duration was
multiplied by an intensity factor to create a physical
activity score that was divided into tertiles and categorized
as low, medium and high. Participants were classified as
current smokers, ex-smokers or never smokers. Alcohol
intake was classified into four categories based on grams of
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alcohol consumed per day: zero-consumers, low (\15 g/
day in women or \20 g/day in men), medium (15–30 g/
day in women or 20–40 g/day in men) and high ([30 g/day
in women or [40 g/day in men). The education variables
were created by classifying participants according to their
highest educational level (B8y, 9–10y, 11–13y, and uni-
versity degree). Season was defined as season of diet data
collection: winter (December–February), spring (March–
May), summer (June–August) and fall (September–
November). Diet assessment method version was defined
as data collection before or after the change of coding
routines in September 1994. Missing values for the vari-
ables were treated as separate categories.
Genotyping
PNPLA3 rs738409 was genotyped using Taqman PCR
method (Applied Biosystems, Foster City, CA USA)
according to manufacturer’s instructions. ABI Prism
Sequence Detection Systems ABI 7900HT (Applied Sys-
tems) was used for post-PCR allelic discrimination by
measuring allele-specific fluorescence. Genotypes were
successfully determined for 96.5 % of the individuals, and
the minor allele frequency was 21 %. The genotype dis-
tribution did not deviate from Hardy–Weinberg equilib-
rium (P = 0.26), and concordance rate of repeated
genotyping of all individuals was 99.9 %.
Statistical analysis
IBM SPSS Statistics version 20.0 was used for all statis-
tical analyses. Statistical significance was set at P \ 0.05.
We examined baseline characteristics across the PNPLA3
genotypes for continuous variables using the general
linear model (GLM) adjusted for age and sex when
applicable. All continuous variables except age were
Ln transformed to achieve normal distribution when
testing for trend across genotypes. Associations between
PNPLA3 genotype and serum triglyceride levels in tertiles
of dietary intakes were evaluated using an additive model
(genotypes coded as 0, 1 or 2 indicating the number of
risk G-alleles) using GLM, adjusting for age and sex in a
basic model and then with additional adjustment for BMI.
Interactions between PNPLA3 genotype and tertiles of
dietary intake on serum triglyceride levels were analyzed
by introducing a multiplicative factor of genotype and diet
tertiles (treated as continuous variables) in addition to
genotype and diet to the models. The multivariate anal-
yses were adjusted for age (continuous) and total energy
intake (continuous) and the following categorical vari-
ables: sex, diet assessment method version, season, leisure
time physical activity, smoking, alcohol intake and edu-
cation. These covariates were identified from the
literature or indicated potential confounding in the MDC
cohort, due to their associations with dietary intakes. The
multivariate analysis was also performed with additional
adjustments for BMI (continuous) and finally also for
fiber intakes. We used 25 kg/m2 as a limit for overweight
following the statements by WHO. As earlier papers
reported association between PNPLA3 I148M and lower
triglyceride levels in obese or insulin resistant individuals,
i.e., 30 kg/m2 in Palmer et al. (2012) and a mean BMI of
28.3 kg/m2 in Krarup et al. (2012), we performed addi-
tional interaction analyses between PNPLA3 genotype
and severe overweight (BMI [ 27.5 kg/m2) and obes-
ity (BMI [ 30 kg/m2) on triglycerides. Interaction anal-
yses with dietary intakes were performed separately
in normal-weight and overweight individuals defining
normal weight as BMI B 25 kg/m2 and overweight as
BMI [ 25 kg/m2).
Results
Interaction between PNPLA3 rs738409 and obesity
status on fasting triglyceride and ALT levels
The clinical characteristics and dietary intakes by the
PNPLA3 rs738409 genotypes and by overweight status
(normal weight defined as BMI B 25 kg/m2 and over-
weight as BMI [ 25 kg/m2) are presented in (Table 1).
Among all individuals without stratification by overweight
status, the rs738409 G-allele associated significantly only
with higher ALT levels (P = 0.005). In contrast to results
in normal-weight individuals, where none of the clinical
variables associated significantly with rs738409, we
observed associations between the G-allele and lower tri-
glyceride-, VLDL-cholesterol- and LDL-cholesterol levels
(P = 0.01, P = 0.002 and P = 0.04), and with higher
ALT levels (P = 0.001) in overweight individuals. Over-
weight (25 kg/m2 C BMI [ 25 kg/m2) modified signifi-
cantly the associations between rs738409 and fasting
triglyceride and ALT levels (Pinteraction = 0.003 and 0.03,
respectively). The interactions were similar with severe
overweight (BMI [ 27.5 kg/m2) and with obesity
(BMI [ 30 kg/m2) (Pinteraction = 0.004 and 0.028, for
fasting triglyceride levels, and Pinteraction = 0.002 and
0.004 for ALT levels, respectively).
Total energy intake and intake levels of CHO, sucrose or
fiber did not significantly differ between the different
rs738409 genotype carriers. The intake levels of x-3 PU-
FAs, x-6 PUFAs and the ratio of them (x-6:x-3 PUFA) did
not differ significantly among the different genotype car-
riers in the whole study group nor among overweight
individuals. However, in the normal-weight individuals
(BMI B 25 kg/m2), G-allele associated with somewhat
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higher intake levels of fiber and x-6:x-3 PUFA ratio
(Table 1).
Interaction analyses between PNPLA3 rs738409
and dietary intake levels of CHO, sucrose and x-6:x-3
PUFA on fasting triglyceride levels
The rs738409 G-allele associated with lower triglyceride
levels in the lowest intake tertile of CHO (P = 0.02) in the
whole study group, and this association was not seen among
normal-weight individuals, but was strong among over-
weight individuals (Table 2). Among the overweight indi-
viduals, the association between the G-allele and lower
triglycerides was only significant in the lowest intake ter-
tiles of CHO and x-6:x-3 PUFA ratio (P = 0.04,
P = 0.001), and similar tendency was observed in the
lowest tertile of sucrose (P = 0.06) (Fig. 1). Among nor-
mal-weight individuals, the G-allele associated with higher
triglycerides among those in the highest sucrose intake
tertile (P = 0.001), whereas no associations were observed
at the lower intakes. Statistical tests for interaction indicated
a tendency for interaction between PNPLA3 rs738409 and
CHO intake (P = 0.07) and sucrose intake (P = 0.07) on
triglyceride levels in the whole study population. The
interaction between rs738409 and sucrose intake on tri-
glyceride levels was nominally significant among normal-
weight individuals (P = 0.03), while among overweight
individuals, a tendency for interaction was observed with x-
6:x-3 PUFA intake ratio (P = 0.08). In sensitivity analyses,
after excluding 932 (19.3 %) individuals with potential
inaccurate energy reporting, the interactions between
PNPLA3 rs738409 and CHO and sucrose intakes on tri-
glyceride levels were somewhat strengthened in all indi-
viduals (P = 0.01 and P = 0.06), while the interaction with
CHO intake was somewhat strengthened and with sucrose
intake somewhat weakened among normal-weight individ-
uals (P = 0.05 for both). The tendency for interaction with
x-6:x-3 PUFA intake ratio in overweight individuals was
weakened (P = 0.20), and all other observations remained
virtually unchanged (see Supplementary table 2).
As we observed a tendency for interaction with the x-
6:x-3 PUFA intake ratio among overweight individuals
and as different dietary fats show a strong correlation with
each other, we performed secondary interaction analyses
with other fat intake variables (intakes of total fat, SFA,
MUFA, PUFA, P:S ratio, x-3 PUFA and x-6 PUFA).
However, we did not observe any significant interactions
(see Supplementary table 3). Adjustments for BMI or for
fiber intake did not markedly change the results. Addi-
tionally, our observations were similar in women and men
(data not shown). The Pearson correlation coefficients
between energy-adjusted dietary intakes are shown in
Supplementary table 4.
Discussion
We investigated the interaction between the PNPLA3
rs738409 (Ile148Met) and overweight and dietary intakes
of CHO, sucrose and x-6:x-3 PUFA ratio on fasting tri-
glyceride levels. Our results indicate that the association
between rs738409 and fasting triglycerides, as well as the
directionality of this association, is dependent on over-
weight and may be modified by dietary intakes of CHO,
sucrose and x-6:x-3 PUFA ratio. Importantly, our results
suggest, using fasting triglyceride levels as a marker for
liver fat accumulation, that the increased hepatic fat
accumulation by 148Met may be a result of both a loss of
function of the hydrolysis activity and/or a gain of function
of the lipid synthase (LPAAT) activity. Moreover, although
we lack the data on liver fat content, our results may
suggest that overweight and dietary intakes may play a role
on which of the defects of PNPLA3 148Met-mutated
protein influences the phenotype.
The proportion of total variation in liver fat content
attributed to rs738409 genotypes is among the strongest
ever reported for common variants that associate with
multifactorial phenotypes. Polymorphisms in three other
genes (GCKR, NCAN and LYPLAL1) have been associ-
ated with liver fat accumulation and NAFLD (Speliotes
et al. 2011), and the NAFLD risk variants of GCKR and
NCAN associate additionally with fasting blood triglyc-
eride levels (Speliotes et al. 2011). However, the NAFLD
risk allele of GCKR associates with elevated, while that of
NCAN with decreased triglyceride levels (Speliotes et al.
2011). The notion that a variant increasing the risk for
hepatic fat accumulation can associate with higher or
lower circulating triglyceride levels is also demonstrated
by our results, suggesting that PNPLA3 148Met is capa-
ble of contributing to both lower or higher circulating
triglyceride levels.
Although the PNPLA3 knock-out mice do not have any
phenotype (Basantani et al. 2011; Chen et al. 2010),
administration of the human mutant PNPLA3 148Met to
the livers of wild-type mice increased their susceptibility of
fatty liver (Huang et al. 2011). In the light of these findings
and our results, it can be speculated that an increased
LPAAT activity of the PNPLA3 148M produces a pheno-
type. In line with this, over-expression of hepatic PNPLA3
of mice markedly increased circulating triglyceride levels
(Qiao et al. 2010). More recently, studies of transgenic
mice over-expressing human PNPLA3 148Met provided
evidence for both increased triglycerides synthesis and
decreased hydrolysis of hepatic triglycerides in these ani-
mals (Li et al. 2012). Further, mice over-expressing the
PNPLA3 148Met developed liver steatosis on high sucrose
diet, which suggests that the PNPLA3 148Met may be
involved in the hepatic de novo lipogenesis (Li et al. 2012).
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Dietary sucrose up-regulates PNPLA3 in both tran-
scriptional and posttranslational level while the PNPLA3 is
virtually absent in fasted animals (Li et al. 2012; Huang
et al. 2010). A high x-6:x-3 PUFA intake ratio has been
shown to stabilize the protein, further contributing to high
levels of PNPLA3 protein (Huang et al. 2010). As also high
FFA levels stabilize PNPLA3, one may speculate that obese
individuals, in whom FFAs in circulation are generally
elevated, may have higher levels of liver PNPLA3. Without
data on liver fat levels in our study, it is not easy to interpret
the results of our study. We can only speculate that the


































































































Fig. 1 Association between the
PNPLA3 rs738409 (Ile148Met)
and fasting blood triglyceride
levels in strata of dietary intake
categories (tertiles of CHO,
sucrose and x-6:x-3 PUFA
ratio) among individuals with
normal weight (BMI B 25 kg/
m2) and overweight
(BMI [ 25 kg/m2) in the
Malmo¨ Diet and Cancer Study-
Cardiovascular Cohort.
Associations were calculated
using general linear model and
additive model for the PNPLA3
genotypes adjusting for age and
sex. Interactions between
genotype and dietary intakes on
serum triglyceride levels were
analyzed by introducing a
multiplicative factor of
genotype and diet tertiles
(treated as continuous variables)
in addition to genotype and diet
to the models. Adjustments
were made for age and total
energy intake (as continuous
variables) and sex, diet
assessment method version,
season, leisure time physical
activity, smoking, alcohol
intake and education (as
categorical variables). Among
normal-weight individuals, the
G-allele associated with higher
triglyceride levels only among
those in the highest sucrose
intake tertile (P = 0.001) but
not at the lower intakes. In
contrast to results in normal-
weight individuals, the G-allele
associated with lower
triglyceride levels among
overweight individuals in the
lowest intake tertiles of CHO,
sucrose and x-6:x-3 PUFA ratio
(p = 0.04, p = 0.06,
p = 0.001). The interaction
between rs738409 and intakes
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overweight carriers of 148Met as lower circulating tri-
glyceride levels, in particular, when dietary intakes of
CHOs, sucrose or x-6:x-3 PUFA ratio were low. In such
environment, the level of PNPLA3 protein can be expected
to be very low, and thus, the loss of the lipase activity could
be the dominating functional defect, as the importance of a
partial loss of function can be expected to increase and that
of any gain-of-function defect to decrease by decreasing
protein levels and vice versa. In line with this, we further
speculate that the reverse enzymatic turning into an
increased LPAAT activity by 148Met may be reflected as
higher triglyceride levels among normal-weight individuals
when the level of PNPLA3 protein is expected to be high,
i.e., when dietary intakes of sucrose and x-6:x-3 PUFA
ratio were high. Two earlier studies have reported interac-
tion between dietary intake of sugar or CHOs (Davis et al.
2010) or x-6:x-3 PUFA ratio and liver fat content, both in
obese children or adolescents. In the first study of 154
overweight Hispanic children, a positive correlation was
observed between hepatic fat content and reported CHO and
sugar intake among children homozygous for 148Met (GG-
genotype), but not among the other genotype carriers.
Similarly, the second study of 127 children and adolescents
of mainly Caucasian origin observed that the x-6:x-3
PUFA intake ratio correlated positively with liver fat con-
tent only among GG-genotype carriers (Santoro et al. 2012).
The main finding of these studies was that the positive
correlation between high intake of sugar or high x-6:x-3
PUFA ratio and liver fat content was restricted to individ-
uals homozygous for 148Met (GG-genotype). Further evi-
dence for that high x-6: x-3 PUFA ratio may be particularly
important for liver injury among the PNPLA3 G-allele
carriers was recently provided by a study of 80 obese
adolescents in which oxidized fatty acids derived from
linoleic acid associated with markers of liver injury only in
risk-genotype carriers (Santoro et al. 2014).
Strengths of our study include the large sample size and
high-quality dietary data, based on a 7-day diet diary and large
questionnaire, with information on many potential con-
founding factors and the ability to identify inaccurate reporters
of energy intake. Still, the main limitation of our study is the
lack of data on hepatic fat content. Another limitation is the
lack of data on fatty acid concentrations, like those of linoleic-
and alpha linolenic acids, which would have been very
informative for the interpretation of the data. Further, we only
had ALT levels analyzed in connection to another study
almost two decades before MDCS and diet data collection,
and therefore, interaction analyses between diet and ALT
would not have been appropriate. On the other hand, associ-
ation analyses between serum ALT levels and PNPLA3
genotypes according to overweight status strengthened our
observation of that the association between 148Met and lower
triglyceride levels, putatively reflecting the hydrolysis defect,
was restricted to overweight individuals and aided at the
interpretation of the results of our study without information
on liver fat levels. Although nutrient habits may differ
between populations, our findings from this population-based
study may be applicable to other westernized countries,
because the nutrient intake levels could by no means be con-
sidered as extreme and are comparable with those from
Swedish national surveys. Finally, we need to emphasize that
we did not correct our analyses for multiple comparisons, and
therefore, the nominally significant or borderline significant
interactions with the dietary intakes in this study must be
interpreted with caution and need to be replicated in other
large studies with dietary data of good quality.
In conclusion, the findings of our epidemiological study
indicate that overweight modifies the association between
PNPLA3 Ile148Met on circulating triglyceride levels and
suggest that dietary intakes of carbohydrates and in par-
ticular sucrose, and possibly x-6:x-3 PUFA ratio, may
additionally modify this association. Our results are in line
with the hypothesis that overweight and high sucrose
intake facilitate liver fat accumulation in 148Met carriers
and may suggest the defective hydrolysis function of
PNPLA3-148Met to be more important in the overweight
state, while the defective increase in LPAAT activity may
be a more important defect when dietary intake of sucrose
is high. It is thus important to challenge the clinical
question of if the excess liver fat accumulation in 148Met
carriers can be eliminated by weight control and reduction
in dietary sucrose intake by intervention studies.
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